Very long-chain fatty acids in erythrocyte membrane sphingomyelin: Detection of ALD hemizygotes and heterozygotes

Neurology

Volumn 36, Issue 6, 1986, Pages 791-795

  Tanaka, Kazuhiko ^a   Shimada, Morimi ^a   Naruto, Toshiyuki ^a   Yamamoto, Hisashi ^a   Saeki, Yukikazu ^a   Sai, Houshun ^b   Hirose, Genjiro ^c  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEHENIC ACID; HEXACOSANOIC ACID; LIGNOCERIC ACID; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BLOOD AND HEMOPOIETIC SYSTEM; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL ARTICLE; DIAGNOSIS; ERYTHROCYTE MEMBRANE; ETIOLOGY; HEMIZYGOTE; HEREDITY; HETEROZYGOTE; HUMAN; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; CHILD; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FEMALE; HETEROZYGOTE; HUMANS; MALE; SPHINGOMYELINS;

EID: 0022475443     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.36.6.791     Document Type: Article

References (17)

1. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP. Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol 1975;32:577–91.
2. Migeon BR, Moser HW, Moser AB, Axelman J, Sillence D, Norum RA. Adrenoleukodystrophy; evidence for X linkage, inac-tivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci USA 1981;78:5066–70.
3. Igarashi M, Schaumburg HH, Powers JM, Kishimoto Y, Kolodny E, Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 1976;26:851–60.
4. Rizzo WB, Avigan J, Chemke J, Schulman JD. Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibro-blasts. Neurology (Cleveland) 1984;34:163–9.
5. Tsuji S, Ohno T, Miyatake T, Suzuki A, Yamakawa T. Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD). J Biochem 1984;96:1241–7.
6. Singh I, Moser AE, Moser HW, Kishimoto Y. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res 1984;18:286–90.
7. Kawamura N, Moser AB, Moser HW, et al. High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients. Biochem Biophys Res Commun 1978;82:114–20.
8. Molzer B, Bernheimer H, Heller R, Toifl K, Vetterlein M. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes. Clin Chim Acta 1982;125:299–305.
9. Tsuji S, Suzuki M, Ariga T, Sekine M, Kuriyama M, Miyatake T. Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy. J Neurochem 1981;36:1046–9.
10. Moser HW, Moser AB, Frayer KK, et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology (NY) 1981;31:1241–9.
11. Moser HW, Moser AE, Trojak JE, Supplee SW. Identification of female carriers of adrenoleukodystrophy. J Pediatr 1983;103:54–9.
12. Post RL, Merritt CR, Kinsolving CR, Albright CD. Membrane adenosine triphosphatase as a participant in the active transport of sodium and potassium in the human erythrocyte. J Biol Chem 1960;235:1796–802.
13. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911–7.
14. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964;5:600–8.
15. Gmiinder J. Uber die Darstellung von Acetylchlorid aus Acetanhydrid mit Hilf von Calciumchlorid. Helv Chimica Acta 1953;36:2021.
16. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466–8.
17. Aubourg P, Bougneres PF, Rocchiccioli F. Capillary gas-liquid chromatographic-mass spectrometric measurement of very long chain (C22 to C26) fatty acids in microliter samples of plasma. J Lipid Res 1985;26:263–7.